Case report: Pembrolizumab plus Axitinib related hypothyroid myopathy in two kidney cancer patients

Overview of attention for article published in Frontiers in oncology, December 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (66th percentile)

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 27,789 followers.

Case report: Pembrolizumab plus Axitinib related hypothyroid myopathy in two kidney cancer patients https://t.co/jtHurw7ZRC https://t.co/bzeMxrTwc5

Did you see this?

RT @FrontOncology: New research: Case report: Pembrolizumab plus Axitinib related hypothyroid myopathy in two kidney cancer patients: The f…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.